Blood transfusions guided by how you feel, not just lab numbers

NCT ID NCT07328191

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether using a simple quality-of-life questionnaire to decide when to give blood transfusions can reduce the number of transfusions needed for people with advanced myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) who are receiving palliative care. Currently, transfusions are given based on hemoglobin levels, but this may not always improve how patients feel. The trial will compare the standard approach with a new one that uses weekly patient-reported well-being scores. About 52 adults will take part, and researchers will track transfusion counts, quality of life, and survival over two months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

red blood cell transfusions guided by a quality-of-life questionnaire

What this could lead to

If it works, this could offer a more personalized way to manage anemia in advanced blood cancers, reducing unnecessary transfusions while keeping patients comfortable.

What could go wrong

This is a small, early-stage study with only 52 participants. The quality-of-life approach may not reduce transfusions or could miss signs that a transfusion is needed, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia anemia myelodysplastic syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Nice

    RECRUITING

    Nice, 06000, France

    Contact